• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov3
Shrader's Focus on Healthcare Industry Stocks
17:02
Oct30
Inmune Bio released FY2025 9 Months earnings on October 30 After-Market EST, actual revenue USD 50K, actual EPS USD -1.7261
23:00
Inmune Bio released FY2025 Q3 earnings on October 30 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2434 (forecast USD -0.325)
23:00
Oct23
Inmune Bio to Release FY2025 Q3 Earnings on October 30 After-Market EST, Forecast EPS USD -0.325
00:05
Aug7
Inmune Bio released FY2025 Semi-Annual earnings on August 7 After-Market EST, with actual revenue of USD 50K and EPS of USD -1.4933
23:00
Inmune Bio released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0497 (forecast USD -0.3816)
23:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.472 M, EPS -0.2434

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -24.46 M, EPS -1.0497

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 50 K, Net Income -9.739 M, EPS -0.4329

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCSA
7.180
+138.94%
+4.175
YCBD
2.324
+62.52%
+0.900
VYNE
0.6003
+49.07%
+0.199
ISPO
4.180
+47.19%
+1.340
ATPC
0.1291
+43.44%
+0.038
UDMY
6.809
+26.80%
+1.435
DBVT
22.650
+25.97%
+4.745
NDLS
0.7634
+23.13%
+0.143
IRBT
0.9261
+21.82%
+0.166
VNRX
0.2949
+21.81%
+0.050
View More